Organon & Co. is a global healthcare company that focuses primarily on the discovery, development, manufacture, and commercialization of therapeutic solutions. Its primary function is to address the n... Organon & Co. is a global healthcare company that focuses primarily on the discovery, development, manufacture, and commercialization of therapeutic solutions. Its primary function is to address the needs of women, with a significant emphasis on family planning and fertility products. Organon operates in important healthcare sectors, notably women’s health, biosimilars, and established brands across various therapeutic areas. The company’s product portfolio includes contraceptive products, fertility treatments, and a range of hormone replacement therapies. Organon was spun off from Merck & Co. in 2021, marking its emergence as a standalone entity aimed at focusing more intensively on women’s health issues. This strategic shift allows Organon to leverage its expertise in pharmaceutical development and expand its reach in global markets, particularly in areas underserved by larger healthcare conglomerates. Situated in the healthcare sector, Organon plays a crucial role by continuing to provide specialized pharmaceuticals designed to meet unique health needs, thereby contributing significantly to public health and therapy innovations.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for Organon & Co

We have not yet reviewed Organon & Co's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Organon & Co's data?

Create a free Tracenable account to signal interest in having our team review data for Organon & Co.

Legal Center Contact Us